Aug 11 (Reuters) - Cipla Ltd, India’s fourth-largest drugmaker by sales, reported a 20 percent rise in quarterly profit, beating analysts’ estimates.
Net profit came in at 4.08 billion rupees ($63.63 million) for the three months ended June 30, compared with 3.39 billion rupees a year earlier, the company, whose U.S. business is small relative to peers, said on Friday. (bit.ly/2uujKnC)
Analysts were on average expecting profit of 3 billion rupees in the first quarter, Thomson Reuters data showed. ($1 = 64.1200 Indian rupees) (Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Muralikumar Anantharaman)